19th Feb 2021 12:52
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Ms V Whyte | |||
b) | Position/status | Company Secretary | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| |||
b) | Nature of the transaction | Transfer of 10,726 Ordinary Shares between accounts for nil consideration.
| |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| £0.00 | 10,726 |
| ||
|
|
|
| ||
d) | Aggregated information | N/A (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2021-02-16 | |||
f) | Place of the transaction
| N/A | |||
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Ms V Whyte | |||
b) | Position/status | Company Secretary | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| |||
b) | Nature of the transaction | Transfer of 10,870 Ordinary Shares to spouse for nil consideration.
| |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| £0.00 | 10,870 |
| ||
|
|
|
| ||
d) | Aggregated information | N/A (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2021-02-18 | |||
f) | Place of the transaction
| N/A | |||
| Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr I Whyte | |||
b) | Position/status | PCA of Ms V Whyte (Company Secretary) | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| |||
b) | Nature of the transaction | Receipt of 10,870 Ordinary Shares from spouse for nil consideration. | |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| £0.00 | 10,870 |
| ||
|
|
|
| ||
d) | Aggregated information | N/A (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2021-02-18 | |||
f) | Place of the transaction
| N/A | |||
Related Shares:
Glaxosmithkline